Venetoclax Combined With Azacitidine and CAG in Refractory/Relapse Acute Myeloid Leukemia
Clinical trial NCT05807347 · UNKNOWN
Trial details
- NCT number
- NCT05807347
- Sponsor
- Hematology department of the 920th hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-02-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.